Drug details
Arranon (nelarabine)
type of Antineoplastics, Antimetabolite
Arranon (nelarabine) is a chemotherapy drug used to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- vomiting,
- diarrhea,
- fever,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- chills,
- tiredness,
- seizure,
- weakness,
- unexplained muscle pain,
- mouth sores,
- muscle cramps,
- skin sores,
- extreme drowsiness,
- tenderness,
- fast or slow heart rate, and
- loss of movement in any part of your body,
- loss of balance or coordination,
- problems walking,
- numbness or tingling feeling in your hands or feet,
- problems with buttoning clothes or picking up small items with your fingers,
- tingling in your hands or feet or around your mouth
The following drugs are related to Arranon, either as a replacement or used together:
- Scemblix (asciminib tablets)
- Rylaze (asparaginase erwinia chrysanthemi (recombinant) - rywn) injection)
- Breyanzi (lisocabtagene maraleucel suspension for intravenous infusion)
- Zynlonta (loncastuximab tesirine-lpyl for injection)
- Ukoniq (umbralisib tablets)